News

India-Brazil Pharma Ties Set for Expansion as Brazil Pushes Joint Drug Manufacturing and API Production

Brazil seeks to deepen pharmaceutical cooperation with India, focusing on local manufacturing and joint ventures

• By PharmaNews Live Desk
• New Delhi
• Feb 19, 2026

News

Brazil has pitched a plan to expand cooperation with India in the pharmaceutical sector by exploring production partnerships and local manufacturing of medicines, officials said, as Brazilian President Luiz Inácio Lula da Silva visits India this week.

Brazil Aims to Shift From Buyer-Seller to Production Partner

During his official visit to India, Brazil’s Health Minister Alexandre Padilha is leading discussions on strengthening ties with Indian drugmakers and public research institutions. The proposal centres on moving beyond a traditional buyer-seller relationship to one rooted in joint production of generic medicines and localisation of active pharmaceutical ingredients (APIs) — substances critical to a medicine’s therapeutic effect — within Brazil.

Padilha, speaking alongside President Lula, described the initiative as part of Brazil’s broader strategy to boost domestic pharmaceutical capacity. He said domestic production would help the country reduce dependence on imported medicines, bolster health security, and create higher-value industrial jobs, while also lowering costs for consumers and the public health system.

Brazil is currently one of the largest consumer markets for Indian healthcare products, prompting officials to aim for deeper industrial collaboration and technology transfer to Brazilian laboratories.

Institutional Bridge to Boost Partnerships

The push for cooperation follows the launch of the Brazilian Association of the Indian Pharmaceutical Industry in Brasilia, intended to serve as an institutional bridge between Indian pharmaceutical firms and the Brazilian market. This association aims to facilitate partnerships, investments and regulatory compliance, potentially smoothing joint ventures and market entry for Indian companies.

India’s envoy to Brazil highlighted India’s role as a key global supplier of affordable medicines — often dubbed the “pharmacy of the world” — and said Indian companies are keen to expand operations in Brazil.

Broadening Cooperation Beyond Trade

Brazil’s delegation includes officials from the country’s health regulator and public research bodies, signalling that discussions extend beyond trade figures to align regulatory frameworks, accelerate drug approvals, and explore collaborations in digital health and AI-enabled smart hospital technologies.

Officials said the pharmaceutical agenda forms part of a broader strategic engagement between the two major Global South economies, which also cooperate as BRICS partners. If agreements materialise, Brazil hopes to achieve lower medicine prices, stronger domestic manufacturing, and longer-term technological capacity through shared expertise with Indian firms.

Part of Wider India-Brazil Engagement

The pharma cooperation push aligns with other India-Brazil efforts to expand economic ties. During President Lula’s visit, both nations are expected to discuss trade, critical minerals, aviation, and broader economic cooperation aimed at boosting bilateral trade and investment.

Analysts see this push as part of a renewed emphasis on strengthening South-South partnerships, particularly between two of the world’s largest emerging markets, as they seek greater self-reliance in strategic sectors and diversification of supply chains.